Venus Remedies Ltd FY26 Annual Report: ₹5.20 Dividend Proposed

Venus Remedies Ltd has released its annual report for FY 2025-26, outlining key resolutions for the upcoming 17th Annual General Meeting (AGM). The company proposes a final dividend of ₹5.20 per equity share for FY26. Additionally, the report details the non-reappointment of Director Mr. Divya Sehgal and the appointment of M/s. Batliboi & Purohit as Joint Statutory Auditors for a three-year term commencing FY27, with an annual remuneration of ₹40 Lakhs. The reappointment of Ms. Geeta Dutta Goel as Non-Executive, Independent Director is also on the agenda.